Show simple item record

Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?

dc.contributor.authorBakir, Baris
dc.contributor.authorIyibozkurt, Cem
dc.contributor.authorAdalet, Isik
dc.contributor.authorMudun, Ayse
dc.contributor.authorTopuz, Samet
dc.contributor.authorTurkmen, Cuneyt
dc.contributor.authorSanli, Yasemin
dc.contributor.authorUnal, Seher
dc.date.accessioned2021-03-05T07:44:40Z
dc.date.available2021-03-05T07:44:40Z
dc.identifier.citationSanli Y., Turkmen C., Mudun A., Adalet I., Unal S., Bakir B., Topuz S., Iyibozkurt C., "Should FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?", JOURNAL OF NUCLEAR MEDICINE, cilt.51, 2010
dc.identifier.issn0161-5505
dc.identifier.othervv_1032021
dc.identifier.otherav_95667434-410f-4be1-8eb4-27e82c1ae484
dc.identifier.urihttp://hdl.handle.net/20.500.12627/100589
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectNükleer Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.titleShould FDG-PET/CT be the first line imaging modality for restaging and/or evaluation of recurrence in patients with ovarian cancer?
dc.typeMakale
dc.relation.journalJOURNAL OF NUCLEAR MEDICINE
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume51
dc.contributor.firstauthorID195951


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record